News

20.02.2019

ARNA has officially become participant of Medical Valley

Company management has visited Medical Valley in Erlangen, Bavaria. We are excited to announce opening of our first European office in Forchheim as part of Softlanding Program provided by Medical […]
13.02.2019

ARNA trade mark is officially registered in Russia

We are excited to announce that our application for registration of ARNA trademark (Russian writing – АРНА) has been approved, which is now officially confirmed by two Certificates for trademarks […]
01.02.2019

ARNA Genomics has been approved for Softlanding Program in Germany

We are excited to inform you that ARNA Genomics US Inc. has been qualified for participation in Softlanding Program in Germany. Participation in this program will allow company to gain […]
31.12.2018

Results of 2018 — a word from CEO

Dear colleagues and friends! In anticipation of the upcoming new 2019, we would like to take summarise results of our work in 2018 and share with you some our plans. […]
15.11.2018

Professor of Sechenov University presented results of a proof-of-concept study of the test ARNA Breast Cancer

During the XXII Russian Oncological Congress professor of Sechenov Medical University, Head of Personalized Oncology Center “OncoTarget”, Marina Sekacheva, presented the results of a proof-of-concept ARNA Breast Cancer test. Results […]
14.11.2018

ARNA took part in the 7th International Forum “Clinical Trials in Russia”

ARNA Genomics CEO Egor Melnikov took part in the discussion “Clinical research of medical devices” at the 7th international forum “Clinical research in Russia”. During the discussion, it was possible […]